BioSpace News Archive

Lyra Therapeutics, Inc . (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Robert Kern, MD has been named Chief Medical Officer. He will also remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology

Antares Pharma, Inc., a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to participate and host investor meetings at the SVB Leerink 10th Annual Virtual Global Healthcare Conference being held on February 22-26, 2021.

Artelo Biosciences, Inc. (NASDAQ: ARTL ) today announced that Saoirse O’Sullivan, Ph.D., Professor of Pharmacology and Scientific Advisor to Artelo, along with Ryan Maguire and Dr. Timothy England of the University of Nottingham, have generated data showing potential pharmacodynamic interactions of co-administration of cannabidiol (CBD) and tetramethylpyrazine (TMP) in cell-based models of cancer.

The Get Iron Informed survey sheds light on knowledge of Iron Deficiency Anemia (IDA) - a condition that impacts one in five women of childbearing age

AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc. , a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the award of a grant from Cure Parkinson’s

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Newport Plastic and Reconstructive Surgery Associates for an investigator-initiated study

Retrospective case series published in the Journal of Shoulder and Elbow Surgery examines 63 shoulders in patients up to 85 years of age; outcomes show significant improvements in motion and patient-reported measures

NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging technology company, announces that it will release its fourth quarter and full year 2020 financial and operating results for the period ended December 31, 2020 on Tuesday, March 2, 2021 prior to the start of trading.

LION Eye Group announces it has entered into a collaborative agreement with OCLI-Spectrum Vision Partners for integrated eye care.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, further clarifies with regards to the final study results released on February 16, 2021 ,